Skip to main content
. 2022 Nov 30;13:1050906. doi: 10.3389/fgene.2022.1050906

TABLE 2.

Clinical data for the GDM patients and NCs in the validation cohort.

GDM (n = 30) NC (n = 30) p value
Maternal age (years) 30.47 ± 3.23 30.03 ± 2.87 0.585
Gestational age (weeks) 38.95 ± 0.61 38.97 ± 0.63 0.885
Prepregnancy BMI 21.71 ± 1.63 22.79 ± 1.67 0.014
BMI at delivery 25.27 ± 1.71 28.11 ± 1.29 <0.0001
Gestational weight gain (kg) 9.17 ± 1.70 13.02 ± 3.14 <0.0001
SBP, mmHg 115.6 ± 8.43 124.8 ± 6.27 <0.0001
DBP, mmHg 70.20 ± 8.19 73.5 ± 7.71 0.114
HBA1c% 5.51 ± 0.26 4.91 ± 0.23 <0.0001
Hemoglobin (g/L) 113.73 ± 8.97 111.97 ± 7.98 0.424
ALT (U/L) 10.43 ± 2.42 9.23 ± 1.61 0.027
AST (U/L) 15.53 ± 2.18 13.97 ± 2.37 0.01
TBA (µmol/L) 2.45 ± 0.87 2.58 ± 0.52 0.512
FBG (mmol/L) 4.84 ± 0.39 4.39 ± 0.36 <0.0001
1-h OGTT (mmol/L) 10.16 ± 1.12 7.69 ± 0.95 <0.0001
2-h OGTT (mmol/L) 8.29 ± 0.96 6.58 ± 0.77 <0.0001
Neonatal birth weight (g) 3483.17 ± 295.41 3396.33 ± 239.86 0.216